BC Extra | Sep 4, 2019
Financial News

Sept. 4 Financial Quick Takes: BrightGene looks to STAR; plus IPO updates from Immunotech, 10x Genomics, SpringWorks, IGM, Satsuma and more

BrightGene advances toward STAR market   The Shanghai Stock Exchange approved an application from BrightGene Bio-Medical Technology Co. Ltd. (Suzhou, China) to raise RMB360 million ($50.3 million) in a listing on its STAR market. If...
BC Extra | Feb 25, 2016
Financial News

PolyPid's D round brings in $22M

PolyPid Ltd. (Petach Tikva, Israel) said it raised $22 million in a series D financing co-led by new investor Shavit Capital and existing investor Aurum Ventures. Chaim Hurvitz, who will now head PolyPid's board, and...
Items per page:
1 - 2 of 2